Daily Roundup

AHC.ASX PME.ASX RDY.ASX 4DX.ASX CAF.ASX

Austco Healthcare Forecasts Strong Profit Growth

Austco Healthcare is heading into the new financial year with momentum on its side. The company expects revenue between $90 million and $95 million, representing growth of 11% to 17% compared to the prior year. More impressively, net profit after tax is projected to jump 52% to 58%, reaching between $9.0 million and $9.4 million. EBITDA should land between $14.0 million and $14.6 million, up 7% to 12%, with margins holding steady around 15.5%.

The growth is being driven by a major US rollout of Pulse Mobile and strong sales momentum across all regions, with new contract wins secured in New Zealand, Australia, Canada, and the United States. The company expects to enter FY27 with a healthy sales pipeline and continued momentum.

Pro Medicus Lands Major Contract Wins and Renewals

Pro Medicus is having a stellar week on the contract front. The healthcare informatics company renewed its relationship with Allegheny Health Network, one of the largest health networks in the Pittsburgh metro area, securing a five-year, A$28 million deal. The renewal includes the addition of Visage 7 Workflow and operates on a transaction-based model with increased minimums and fees, offering potential upside. This marks the third term of their partnership.

Separately, Pro Medicus signed a seven-year, A$16 million contract with TidalHealth, another significant win in the US market. The deal includes the full Visage 7 suite—Viewer, Workflow, Open Archive, and Cardiology Imaging—all implemented in the cloud. Implementation kicks off immediately, with a targeted go-live in Q1 2027.

In an interview, CEO Dr. Sam Hupert highlighted the significance of these wins alongside recent contracts with Beth Israel Lahey Health and University of Maryland. He noted that while the market initially reacted negatively to AI concerns, these recent wins suggest a potential shift in sentiment. Most revenue from the company's large implementations will flow through in FY27, with a material step-up in transaction volumes expected in the first half of that year. FY26 revenue is on track to more than double FY24 levels.

4DMedical Expands into Europe

4DMedical is taking its respiratory imaging technology global through the acquisition of contextflow, an Austrian-based medical technology company. The deal provides immediate commercial and clinical footing in Europe and includes a CE-marked lung cancer screening solution—a significant advantage for entering the regulated European market.

The transaction involves upfront payments of approximately A$18.56 million in cash and shares, plus earnout options of up to 2.59 million based on performance milestones. 4DMedical also retains €19.0 million in accumulated tax losses from the acquisition. The European market for respiratory diagnostics is estimated at USD $1.5 to $2 billion, offering substantial growth potential. The acquisition positions 4DMedical across three continents, significantly enhancing its global footprint.

Centrepoint Alliance Bolsters Queensland Presence

Centrepoint Alliance has acquired the client books and servicing employed advisers from Cairns Wealth and Pinnacle Wealth, expanding its footprint in Queensland and strengthening its strategic alignment with Astute Financial Management. The transaction is valued at approximately $3.0 million and is expected to contribute $0.60 to $0.65 million in EBIT, making it earnings accretive in FY27. The acquisition is funded through a new $10 million facility from National Australia Bank, giving the company firepower for future growth.

ReadyTech Rejects Takeover Bid

ReadyTech Holdings has rejected an unsolicited acquisition proposal from Total Specific Solutions, which offered $2.00 per share for 100% of the company. The board determined the offer undervalued the business in a change of control context and deemed it unexecutable. The proposal also came with a 50.1% minimum acceptance condition at a lower $1.75 per share. Shareholders have been advised not to take any action. Trading in ReadyTech's shares has been temporarily paused pending further announcements.